Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS
Implementation and Evaluation of a Screening Strategy to Reduce Morbidity and Mortality Due to Cryptoccocal Meningo-encephalitis in ART Naive AIDS Patients With <100 CD4 Count at the Day Hospital of the Yaounde Central Hospital, Cameroon
Sponsor: ANRS, Emerging Infectious Diseases
Listed as NCT02624453, this NA trial focuses on Cryptococcal Meningitis and remains ongoing. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status NA
▶ Show 4 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS, Emerging Infectious Diseases
- St George's, University of London
- Yaounde Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .